Global Energy Drinks Market to Surge Significantly at a CAGR of ~8% by 2030 | DelveInsight
28 nov. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Global Energy Drinks Market to Surge Significantly at a CAGR of ~8% by 2030 | DelveInsight The rising demand for health and fitness products,...
Global Human Growth Hormones Market to Reach USD 10 Billion by 2030 | DelveInsight
27 nov. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Global Human Growth Hormones Market to Reach USD 10 Billion by 2030 | DelveInsight The rising demand for human growth hormones is largely driven by...
Global Peripheral Artery Disease Treatment Market to Grow at a CAGR of ~7% by 2030 | DelveInsight
26 nov. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Global Peripheral Artery Disease Treatment Market to Grow at a CAGR of ~7% by 2030 | DelveInsight The demand for peripheral artery disease treatment...
Neuroendocrine Tumors Market to Showcase Rapid Growth During the Study Period (2020–2034), at a CAGR of 5.1%| DelveInsight
25 nov. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Neuroendocrine Tumors Market to Showcase Rapid Growth During the Study Period (2020–2034), at a CAGR of 5.1%| DelveInsight The launch of upcoming...
Global Antacids Market to Cross ~USD 9 Billion Mark by 2030 | DelveInsight
21 nov. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Global Antacids Market to Cross ~USD 9 Billion Mark by 2030 | DelveInsight The rising need for antacids is primarily driven by key factors such as...
Hidradenitis Suppurativa Market to Showcase Remarkable Growth at a CAGR of 12.4% by 2034 | DelveInsight
20 nov. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Hidradenitis Suppurativa Market to Showcase Remarkable Growth at a CAGR of 12.4% by 2034 | DelveInsight According to DelveInsight’s analysis, the...
Advancing Stargardt Disease Treatments: 20+ Companies Poised to Accelerate the Therapeutic Pipeline | DelveInsight
19 nov. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Advancing Stargardt Disease Treatments: 20+ Companies Poised to Accelerate the Therapeutic Pipeline | DelveInsight Advancements in gene therapy is a...
Human Papillomavirus Market is Projected to Boost at a Moderate Growth Rate During the Study Period (2020–2034) | DelveInsight
18 nov. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Human Papillomavirus Market is Projected to Boost at a Moderate Growth Rate During the Study Period (2020–2034) | DelveInsight According to...
Global Organoids Market to Surge Significantly at a CAGR of ~14% by 2030 | DelveInsight
14 nov. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Global Organoids Market to Surge Significantly at a CAGR of ~14% by 2030 | DelveInsight The demand for organoids is being driven mainly by an...
NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight
13 nov. 2024 12h30 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment |...